-+ 0.00%
-+ 0.00%
-+ 0.00%
CBD 3Q26 adjusted EBITDA rises 17% to R$ 482 million vs. 3Q25
Share
Listen to the news
CBD 3Q26 adjusted EBITDA rises 17% to R$ 482 million vs. 3Q25
  • CBD’s third-quarter 2026 adjusted consolidated net loss narrowed 33% from a year earlier to R$ 264 million.
  • Adjusted EBITDA rose 17% year over year to R$ 482 million.
  • The extrajudicial reorganization plan secured court approval, with issuance of new securities related to affected claims scheduled for December 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CBD - Companhia Brasileira de Distribuição published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending